Company news

Shanghai Hile Bio-technology Co Ltd Class A (SSE:603718) news

Shanghai Hile Bio-technology Co Ltd Class A news releases on 6ix. Latest, Aug 29, 2026: "SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Announcement on Resolutions…

Shanghai Hile Bio-technology Co Ltd Class A (SSE:603718) news

Press releases & updates

"SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Announcement on Resolutions of the 22nd Meeting of the 5th Board of Directors

"SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Announcement on Completion of Industrial and Commercial Registration Changes

"SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Announcement on Completion of Repurchase and Cancellation of the Remaining Restricted Shares under the 2023 Restricted Share and Stock Option Incentive Plan

"SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Indicative Announcement on Internal Transfer of Shares by Agreement between Controlling Shareholder and Its Persons Acting in Concert and Resulting Change in Equity

"SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Announcement on Implementation of Repurchase and Cancellation of Remaining Restricted Shares under the 2023 Restricted Share and Stock Option Incentive Plan

"SHANGHAI HILE BIO-TECHNOLOGY CO., LTD."Announcement on the Reply to the Shanghai Stock Exchange's "Information Disclosure Regulatory Inquiry Letter on the Company's 2025 Annual Report"

"HUNAN HAILI CHEMICAL INDUSTRY CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Reply to the Letter of Regulation from the Shanghai Stock Exchange Regarding Shanghai Hile Bio-Technology Co., Ltd.'s Outward Investment Matters

Announcement on Completion of Industrial and Commercial Change Registration for the Acquisition of Equity in Hunan Zeerdun New Materials Co., Ltd. by a Holding Subsidiary

Announcement on the Completion of Cancellation of Stock Options under the 2023 Restricted Stock and Stock Option Incentive Plan

Announcement on Progress in the Acquisition of Equity Interests in Hunan Zirdent New Materials Co., Ltd. by the Holding Subsidiary

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Daily Wholly-owned Subsidiaries Purchasing Raw Materials from Related Parties and Related Party Transactions

Announcement on Progress in Outward Investment in Establishing a Second-tier Subsidiary

Announcement on Progress in Acquisition of Equity in Dental Chain Companies by the Holding Subsidiary

Announcement on Wholly-owned Obtaining Invention Patent by its Wholly-owned Subsidiary

Announcement on Implementation of Delisting Risk Warning and Suspension of Stock Trading

Announcement on 3rd Risk Alert of Possible Implementation of Delisting Risk Warning on Company Shares

Announcement on 2nd Risk Alert of Possible Implementation of Delisting Risk Warning on Company Shares

Announcement on Resolutions of the 19th Meeting of the 5th Board of Directors

Announcement on Holding Subsidiary Re-certified as High-tech Enterprise

Announcement on Registration Certificate Obtained in Indonesia for Products of a Holding Subsidiary

Announcement on Registration Certificate Obtained in Vietnam for Products of a Holding Subsidiary

Announcement on Wholly-owned Subsidiary Obtaining Government Subsidies

Announcement on 2nd-tier Subsidiary's Product Obtaining Class III Medical Device Registration Certificate

Announcement on Completion and Share Increase Results of the Share Increase Plan for Director and General Manager

Announcement on Obtaining High-tech Enterprise Certificate by the Second-tier Subsidiary

Earnings Preannouncement for 2025

Announcement on the Change of Medical Device Production License of a Wholly-owned Subsidiary

Announcement on Completing Industrial and Commercial Change Registration

Announcement on Completion of Repurchase and Cancellation of Some Restricted Stocks Under the 2023 Restricted Stock and Stock Option Incentive Plan

Announcement on Implementation of Repurchase and Cancellation of Some Restricted Stocks Under the 2023 Restricted Stock and Stock Option Incentive Plan

Announcement on Acquisition of Equity in Seven Dental Chain Companies in Yangzhou and Changzhou by the Holding Subsidiary

Announcement on the Completion of Cancellation of Some Stock Options under the 2023 Restricted Stock and Stock Option Incentive Plan

Announcement on the Progress of Acquisition of Minority Equity in Holding Subsidiary and the Completion of Industrial and Commercial Change Registration

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

Announcement on Resolutions of the 17th Meeting of the 5th Board of Directors

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

Announcement on Convening the Q3 2025 Performance Briefing

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

Announcement on Adjusting the Transaction Price for Major Asset Purchase and Signing Supplementary Agreement

Announcement on Acceptance of the Registration Application for Class III Medical Devices by the Holding Subsidiary

Announcement on Convening the 2025 Semi-annual Performance Briefing

Announcement on Implementation of Dividend Distribution for 2024

Announcement on Reply to Regulatory Letter from the Shanghai Stock Exchange Regarding Information Disclosure of the 2024 Annual Report of Shanghai Hile Bio-Technology Co., Ltd.

Announcement on the Expiration of the Plan for the Director and General Manager to Reduce Shareholdings through Centralized Bidding and the Result of No Shares Being Sold

Announcement on Resolution of the 2024 Annual General Meeting

Indicative Announcement on Equity Changes Due to Shareholders Holding 5% Shares Reducing Their Shareholding below 5%

Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 1%

Announcement on the Result of Share Reduction by Shareholders Holding over 5% of Shares